EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association between deletions in the preS1/2 region of the hepatitis B virus genome and persistently abnormal ALT levels in patients with chronic hepatitis B treated with nucleos(t)ide analogs

Yurina Sato, Kotaro Doi, Jun Inoue, Masashi Ninomiya, Mio Tsuruoka, Kosuke Sato, Masazumi Onuki, Satoko Sawahashi, Keishi Ouchi, Kengo Watanabe, Hirofumi Niitsuma, Atsushi Masamune

Archives of Virology · 2026

DOI: 10.1007/s00705-025-06480-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Virology, 2026. Verfasst von Yurina Sato und 11 weiteren Autor:innen. Beteiligte Einrichtung: Tohoku University School of Medicine, Sendai, Japan. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hepatitis B virus, Antiviral Agents, Alanine Transaminase. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with chronic hepatitis B (CHB) are at risk of developing hepatocellular carcinoma (HCC) during treatment with nucleos(t)ide analogs (NAs). Several factors, including abnormal ALT levels during NA treatment, are associated with HCC risk; however, the mechanisms of ALT abnormalities remain unknown. Here, deletions in the preS1/2 region of the hepatitis B virus (HBV) genome were evaluated in the context of persistent ALT abnormalities after NA treatment. Out of the 198 patients with CHB who had been treated with NAs, 40 who had been treated with entecavir, tenofovir disoproxil fumarate, or tenofovir alafenamide fumarate as the first-line therapy and from whom serum samples had been collected before NA treatment were selected for analysis of the infecting virus. Total DNA was extracted from the samples and subjected to nested PCR to detect deletions in the preS1/2 region of the HBV genome. Patients for whom deletions were found in ≥ 40% of the amplicons were classified as the "high-del" group, and the others were the "low-del" group. The preS1/2 region was amplified from 39 (97.5%) of the 40 samples, and a deletion was found in 19 of these patients (48.7%). The cumulative incidence of HCC was found to be significantly higher in the high-del group than in the low-del group (25% vs. 7% at 2 years, P = 0.021). The high-del group also had significantly higher ALT levels than the low-del group after 1 year of NA treatment (35 vs. 26 U/L, P = 0.020). In summary, patients with CHB with frequent preS1/2 deletions showed higher ALT levels after NA treatment and a higher risk of developing HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicHepatitis B virusAntiviral AgentsAlanine TransaminaseHepatitis B Surface AntigensSequence DeletionProtein PrecursorsHumansMaleMiddle AgedFemaleAdultDNA, ViralAgedNucleosidesGenome, ViralNucleotidesCarcinoma, Hepatocellular

Substanzen

Antiviral AgentsAlanine TransaminaseHepatitis B Surface AntigensDNA, Viralpresurface protein 1, hepatitis B surface antigenProtein Precursorspresurface protein 2, hepatitis B surface antigenNucleosidesNucleotides

Autor:innen und Institutionen

  • Tohoku University School of Medicine, Sendai, Japan.
  • Division of Gastroenterology, Tohoku University Graduate School of Medicine, 980-8574, Sendai, Japan.
  • Division of Gastroenterology, Tohoku University Graduate School of Medicine, 980-8574, Sendai, Japan. jinoue-drgn@umin.net.
  • Institute for Excellence in Higher Education, Tohoku University, Sendai, Japan. jinoue-drgn@umin.net.
  • Institute for Excellence in Higher Education, Tohoku University, Sendai, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Sato, Y., Doi, K., Inoue, J., Ninomiya, M., Tsuruoka, M., Sato, K., Onuki, M., Sawahashi, S., Ouchi, K., Watanabe, K., Niitsuma, H., & Masamune, A. (2026). Association between deletions in the preS1/2 region of the hepatitis B virus genome and persistently abnormal ALT levels in patients with chronic hepatitis B treated with nucleos(t)ide analogs. Archives of Virology. https://doi.org/10.1007/s00705-025-06480-6

Vancouver

Sato Y, Doi K, Inoue J, Ninomiya M, Tsuruoka M, Sato K, et al. Association between deletions in the preS1/2 region of the hepatitis B virus genome and persistently abnormal ALT levels in patients with chronic hepatitis B treated with nucleos(t)ide analogs. Archives of Virology. 2026. doi:10.1007/s00705-025-06480-6

BibTeX
@article{Sato2026,
  author = {Sato, Yurina and Doi, Kotaro and Inoue, Jun and Ninomiya, Masashi and Tsuruoka, Mio and Sato, Kosuke and Onuki, Masazumi and Sawahashi, Satoko and Ouchi, Keishi and Watanabe, Kengo and Niitsuma, Hirofumi and Masamune, Atsushi},
  title = {Association between deletions in the preS1/2 region of the hepatitis B virus genome and persistently abnormal ALT levels in patients with chronic hepatitis B treated with nucleos(t)ide analogs},
  journal = {Archives of Virology},
  year = {2026},
  doi = {10.1007/s00705-025-06480-6}
}
Kostenlos starten →